Activities in the industry differ depending on the stage in a drug’s development. Before a drug can be marketed the industry has to demonstrate appropriate manufacturing standards and establish the drug’s risk-benefit profile (using information from toxicology and clinical trials). The prospectively collected safety and efficacy data are put before the regulatory authorities, who evaluate whether the efficacy demonstrated outweighs the risk (or potential risk).
Where the balance is favourable the drug may be approved for marketing. If it is approved, post-marketing activities include marketing for any indications agreed with the local regulatory authority and continuous safety monitoring. Additional clinical trials (phase IV) may be undertaken.
Most drugs don’t make it to the market, so their research and development costs are recouped by the few that do. More.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.